To further validate the anti‐inflammatory effect of IL‐37 administration on M1 macrophages during SARS‐CoV‐2 Omicron infection, we induced the differentiation of mouse bone marrow (BM)‐derived cells into M1 macrophages in vitro (Figure 5A). The gene discussed is IL37; the disease is infection.